Sean Wuxiong Cao Exercises Options at NovaBridge Biosciences (NBP) — SEC Form 4, Sep 08, 2026
SEC Form 4 · No Market Transaction
Option Exercise
Derivative exercise — no open market transaction.
Equity Position
374K sh
35,073 → 374,445
Equity Change
+967.6%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Sean Wuxiong Cao CIK 0002109966 |
Officer
|
Sean Wuxiong Cao at NovaBridge Biosciences
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$122,488
More from this insider at NovaBridge Biosciences
| 2026-09-11 | Sell | -$79,904 | View |
| 2026-06-24 | Award | — | View |
| 2026-05-18 | Sell | -$42,584 | View |
Non-Derivative Securities Transactions
Derivative Securities Transactions
Footnotes (6)
- F1
- The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer. Show more
- F2
- Reported securities are represented by 102,233 ADSs Show more
- F3
- Each restricted stock unit ("RSU") represents a contingent right to receive one ADS. Show more
- F4
- Reported securities are represented by 45,320 ADSs. Show more
- F5
- On September 3, 2025, the Reporting Person was granted 408,933 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the third day of each third month. Show more
- F6
- On June 22, 2026, the Reporting Person was granted 181,280 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on September 3, 2026 and the balance vesting ratably over the subsequent 12 quarters on the third day of each third month. Show more
Related filings at NovaBridge Biosciences
Institutional Holders
13F holders · Sep 30, 2026
47
institutional managers reporting a position
Largest by reported value
- Hhlr Advisors, Ltd. $8.16M
- Morgan Stanley $4.74M
- Aihc Capital Management Ltd $3.93M
5%+ Holders · 13D/G
3 filers
-
Hhlr Advisors, Ltd. 4.9%
Other insiders at NovaBridge Biosciences
GET /v1/forms/4/0002109966-26-000006
API docs
View Original SEC Filing